Clinical Trial Update: Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for Refractory Diabetic Macular Edema (IBEME Study) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing intravitreal triamcinolone acetonide to intravitreal bevacizumab for refractory diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (intravitreal) (bevacizumab)
• Triamcinolone acetonide (intravitreal) (triamcinolone acetonide)

Snippet

Sponsor: University of Sao Paulo | Conditions: Diabetic Macular Edema | Phase 1 | Status: UNKNOWN